Financial Statements/ESG Information - [Interim/Half-Year Report]

OrbusNeich Medical Group Holdings Limited operates as a medical device manufacturer. The Company develops, manufactures, and distributes interventional instruments for percutaneous coronary intervention (PCI) and percutaneous transluminal angioplasty (PTA) procedures. OrbusNeich Medical Group Holdings markets its products in Asia, Europe, America, and other countries and regions.

OrbusNeich Medical Group Holdings (6929 HK)

Interim Report 2024

Announcements and Notices - [Interim Results]

Announcement Of Interim Results
For The Six Months Ended June 30, 2024

Announcements and Notices - [Date of Board Meeting]

Date Of Board Meeting

Announcements and Notices - [Profit Warning / Inside Information]

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Interim Report 2024

Announcement Of Interim Results For The Six Months Ended June 30, 2024

Date Of Board Meeting

Profit Warning

Amended And Restated Memorandum Of Association And Second Amended And Restated Articles Of Association